A Diabetes Study to Treat A Population Previously Not at Target

Inclusion Criteria: * Diagnosis of Type 2 diabetes * Previously treated with a commonly accepted start dose of a statin for the last 4 weeks prior to study entry * Fasting LDL-C concentration of \> 2.0 mmol/L (and ≤ 5.0 mmol/L) (in the past 3 months) * History of serum TG level of ≤ 4.6 mmol/l (in the past 3 months) Exclusion Criteria: * If currently receiving therapy with any statin at a dose higher than listed * Rosuvastatin (current use) * Fibrates, niacin or resins that was not discontinued a minimum of 2 months prior to enrolment. * Type 1 diabetes; glycated haemoglobin (HbA1c) \> 9.0% * Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) level ≥ 1.5 × upper limit of normal (ULN) (in the past 2 months) * Resting diastolic or systolic blood pressure of \> 95 mmHg or \> 180 mmHg, respectively (in the past 2 months) * Unexplained serum creatine kinase (CK) level \> 3 × ULN (in the past 2 months).